| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8445867 | European Journal of Cancer | 2012 | 8 Pages |
Abstract
Use of statin or statin + ACEi medication during radical pelvic radiotherapy significantly reduces acute gastrointestinal symptoms scores and also appears to provide longer-term sustained protection.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Linda J. Wedlake, Foteini Silia, Barbara Benton, Amyn Lalji, Karen Thomas, David P. Dearnaley, Peter Blake, Diana Tait, Vincent S. Khoo, H. Jervoise N. Andreyev,